Efficacy of ceftazidime-avibactam with or without polymyxin for carbapenem-resistant Klebsiella pneumoniae infections after initial treatment with polymyxin

多粘菌素B 多粘菌素 医学 肺炎克雷伯菌 头孢他啶/阿维巴坦 内科学 头孢他啶 碳青霉烯 粘菌素 死亡率 抗生素 外科 重症监护医学 铜绿假单胞菌 微生物学 生物 细菌 遗传学 大肠杆菌 基因 生物化学
作者
Jingli Lü,Yani Ma,Zhe Cao,Baoling Zhu,Li Fan,Haiyang Meng
出处
期刊:Microbiology spectrum [American Society for Microbiology]
卷期号:13 (1): e0177024-e0177024 被引量:3
标识
DOI:10.1128/spectrum.01770-24
摘要

ABSTRACT Although polymyxins are a suboptimal option for difficult-to-treat resistant infections, they are still preferred as the first-line treatment, especially in low- and middle-income countries. This study assesses the efficacy of ceftazidime-avibactam (CAZ-AVI) following polymyxin B failure in patients with carbapenem-resistant Klebsiella pneumoniae (CRKP) infections. We retrospectively reviewed cases of infections caused by CRKP in adults who received CAZ-AVI as salvage therapy. Clinical features and outcomes were described, and a logistic regression model was used to assess the risk factors associated with in-hospital crude mortality. One hundred and six patients were included in this study. The median age was 56 years. The most common infectious sites were lung. The patients received CAZ-AVI as salvage therapy for a median duration of 9 days following initial treatment with polymyxin B (median, 12.5 days). Also, 91 (85.8%) patients received CAZ-AVI combination therapy, and 34 (32.1%) patients received CAZ-AVI in combination with polymyxin B. The rate of in-hospital crude mortality was 25.5% (27/106), with the highest rate observed in patients treated with regimens containing polymyxin B (41.2%; 14/34). Therapeutic response was observed in 81 (76.4%) patients, with microbiological eradication achieved in 77.1% (74/96) of cases. Multivariable analysis identified that the length of intensive care unit stays, the sequential organ failure assessment (SOFA) score at CAZ-AVI withdrawal, and regimens containing polymyxin B were independently associated with in-hospital mortality, whereas the duration of CAZ-AVI treatment was independently associated with survival. CAZ-AVI salvage therapy demonstrated improved survival outcomes in patients who experienced failure with polymyxin B therapy. IMPORTANCE For patients with carbapenem-resistant Klebsiella pneumoniae (CRKP) infections, published experience with salvage therapy is limited after the failure of polymyxin-based initial therapy. Here, we found that ceftazidime-avibactam salvage therapy for patients with CRKP infections offers benefit in mortality.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
1秒前
DJ完成签到 ,获得积分10
1秒前
慕青的应助被瓜瓜采纳,获得10
1秒前
hu完成签到 ,获得积分10
2秒前
结实的胡萝卜完成签到,获得积分10
2秒前
生化环材的生化环材完成签到,获得积分10
2秒前
乔凌云完成签到 ,获得积分10
2秒前
怡然的凌兰完成签到,获得积分10
2秒前
2秒前
平淡的惜芹完成签到,获得积分10
3秒前
CodeCraft的应助被星空采纳,获得10
3秒前
深情安青的应助被海洋蝌蚪采纳,获得10
3秒前
热情小凡完成签到,获得积分10
3秒前
jklwss完成签到,获得积分10
3秒前
swent_66完成签到,获得积分10
3秒前
3秒前
jg完成签到,获得积分10
3秒前
3秒前
zhabgyyy完成签到,获得积分10
4秒前
4秒前
4秒前
12发布了新的文献求助10
4秒前
hjabao完成签到,获得积分10
4秒前
丘比特的应助被慕念采纳,获得10
4秒前
5秒前
八倍速生活完成签到,获得积分10
5秒前
QDU的应助被吾吾采纳,获得10
5秒前
6秒前
6秒前
顺心的曲奇完成签到,获得积分10
7秒前
安静破茧完成签到,获得积分10
7秒前
便便民工完成签到,获得积分20
7秒前
8秒前
光亮向真发布了新的文献求助10
8秒前
lkk完成签到,获得积分10
8秒前
香蕉觅云的应助被失物爱采纳,获得10
8秒前
zhh发布了新的文献求助10
8秒前
冲就完了发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570437
关于积分的说明 21812406
捐赠科研通 7776516
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557516
邀请新用户注册赠送积分活动 2479162